Copyright Reports & Markets. All rights reserved.

Global and Japan Pneumococcal Polysaccharide Vaccine Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Pneumococcal Polysaccharide Vaccine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Pneumococcal Polysaccharide Vaccine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type
    • 1.4.2 Single Dose Vial
    • 1.4.3 Pre-Filled Syringe
  • 1.5 Market by Application
    • 1.5.1 Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application
    • 1.5.2 Children (2-10 Age)
    • 1.5.3 Adult (10-64 Age)
    • 1.5.4 Geriatric (More Than 65 Age)
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Pneumococcal Polysaccharide Vaccine Market Size, Estimates and Forecasts
    • 2.1.1 Global Pneumococcal Polysaccharide Vaccine Revenue 2015-2026
    • 2.1.2 Global Pneumococcal Polysaccharide Vaccine Sales 2015-2026
  • 2.2 Global Pneumococcal Polysaccharide Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Pneumococcal Polysaccharide Vaccine Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2021-2026)

3 Global Pneumococcal Polysaccharide Vaccine Competitor Landscape by Players

  • 3.1 Global Top Pneumococcal Polysaccharide Vaccine Sales by Manufacturers
    • 3.1.1 Global Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Pneumococcal Polysaccharide Vaccine Manufacturers by Revenue
    • 3.2.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Pneumococcal Polysaccharide Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Pneumococcal Polysaccharide Vaccine Revenue in 2019
    • 3.2.5 Global Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Pneumococcal Polysaccharide Vaccine Price by Manufacturers
  • 3.4 Global Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Product Types
    • 3.4.1 Pneumococcal Polysaccharide Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Pneumococcal Polysaccharide Vaccine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Pneumococcal Polysaccharide Vaccine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Pneumococcal Polysaccharide Vaccine Market Size by Type (2015-2020)
    • 4.1.1 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2015-2020)
    • 4.1.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2015-2020)
    • 4.1.3 Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Pneumococcal Polysaccharide Vaccine Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2021-2026)
    • 4.2.3 Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Pneumococcal Polysaccharide Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Pneumococcal Polysaccharide Vaccine Market Size by Application (2015-2020)
    • 5.1.1 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2015-2020)
    • 5.1.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2015-2020)
    • 5.1.3 Pneumococcal Polysaccharide Vaccine Price by Application (2015-2020)
  • 5.2 Pneumococcal Polysaccharide Vaccine Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Pneumococcal Polysaccharide Vaccine Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application

  • 6.1 Japan Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2015-2026
    • 6.1.1 Japan Pneumococcal Polysaccharide Vaccine Sales YoY Growth 2015-2026
    • 6.1.2 Japan Pneumococcal Polysaccharide Vaccine Revenue YoY Growth 2015-2026
    • 6.1.3 Japan Pneumococcal Polysaccharide Vaccine Market Share in Global Market 2015-2026
  • 6.2 Japan Pneumococcal Polysaccharide Vaccine Market Size by Players (International and Local Players)
    • 6.2.1 Japan Top Pneumococcal Polysaccharide Vaccine Players by Sales (2015-2020)
    • 6.2.2 Japan Top Pneumococcal Polysaccharide Vaccine Players by Revenue (2015-2020)
  • 6.3 Japan Pneumococcal Polysaccharide Vaccine Historic Market Review by Type (2015-2020)
    • 6.3.1 Japan Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
    • 6.3.2 Japan Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2015-2020)
    • 6.3.3 Japan Pneumococcal Polysaccharide Vaccine Price by Type (2015-2020)
  • 6.4 Japan Pneumococcal Polysaccharide Vaccine Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 Japan Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2021-2026)
    • 6.4.2 Japan Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2021-2026)
    • 6.4.3 Japan Pneumococcal Polysaccharide Vaccine Price Forecast by Type (2021-2026)
  • 6.5 Japan Pneumococcal Polysaccharide Vaccine Historic Market Review by Application (2015-2020)
    • 6.5.1 Japan Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
    • 6.5.2 Japan Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2015-2020)
    • 6.5.3 Japan Pneumococcal Polysaccharide Vaccine Price by Application (2015-2020)
  • 6.6 Japan Pneumococcal Polysaccharide Vaccine Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 Japan Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2021-2026)
    • 6.6.2 Japan Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2021-2026)
    • 6.6.3 Japan Pneumococcal Polysaccharide Vaccine Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2015-2026
  • 7.2 North America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
    • 7.2.1 North America Pneumococcal Polysaccharide Vaccine Sales by Country (2015-2020)
    • 7.2.2 North America Pneumococcal Polysaccharide Vaccine Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2015-2026
  • 8.2 Europe Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
    • 8.2.1 Europe Pneumococcal Polysaccharide Vaccine Sales by Country
    • 8.2.2 Europe Pneumococcal Polysaccharide Vaccine Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2015-2026
  • 10.2 Latin America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
    • 10.2.1 Latin America Pneumococcal Polysaccharide Vaccine Sales by Country
    • 10.2.2 Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country
    • 11.2.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Merck & Co., Inc.
    • 12.1.1 Merck & Co., Inc. Corporation Information
    • 12.1.2 Merck & Co., Inc. Description and Business Overview
    • 12.1.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Products Offered
    • 12.1.5 Merck & Co., Inc. Recent Development
  • 12.2 Pfizer Inc.
    • 12.2.1 Pfizer Inc. Corporation Information
    • 12.2.2 Pfizer Inc. Description and Business Overview
    • 12.2.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Pfizer Inc. Pneumococcal Polysaccharide Vaccine Products Offered
    • 12.2.5 Pfizer Inc. Recent Development
  • 12.3 Glaxosmithkline Plc.
    • 12.3.1 Glaxosmithkline Plc. Corporation Information
    • 12.3.2 Glaxosmithkline Plc. Description and Business Overview
    • 12.3.3 Glaxosmithkline Plc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Products Offered
    • 12.3.5 Glaxosmithkline Plc. Recent Development
  • 12.4 Sanofi Pasteur
    • 12.4.1 Sanofi Pasteur Corporation Information
    • 12.4.2 Sanofi Pasteur Description and Business Overview
    • 12.4.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Products Offered
    • 12.4.5 Sanofi Pasteur Recent Development
  • 12.5 China National Biotec Group
    • 12.5.1 China National Biotec Group Corporation Information
    • 12.5.2 China National Biotec Group Description and Business Overview
    • 12.5.3 China National Biotec Group Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 China National Biotec Group Pneumococcal Polysaccharide Vaccine Products Offered
    • 12.5.5 China National Biotec Group Recent Development
  • 12.6 Astellas Pharma Inc
    • 12.6.1 Astellas Pharma Inc Corporation Information
    • 12.6.2 Astellas Pharma Inc Description and Business Overview
    • 12.6.3 Astellas Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Products Offered
    • 12.6.5 Astellas Pharma Inc Recent Development
  • 12.7 Serum Institute of India Pvt. Ltd
    • 12.7.1 Serum Institute of India Pvt. Ltd Corporation Information
    • 12.7.2 Serum Institute of India Pvt. Ltd Description and Business Overview
    • 12.7.3 Serum Institute of India Pvt. Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Products Offered
    • 12.7.5 Serum Institute of India Pvt. Ltd Recent Development
  • 12.8 MSD
    • 12.8.1 MSD Corporation Information
    • 12.8.2 MSD Description and Business Overview
    • 12.8.3 MSD Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 MSD Pneumococcal Polysaccharide Vaccine Products Offered
    • 12.8.5 MSD Recent Development
  • 12.11 Merck & Co., Inc.
    • 12.11.1 Merck & Co., Inc. Corporation Information
    • 12.11.2 Merck & Co., Inc. Description and Business Overview
    • 12.11.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Products Offered
    • 12.11.5 Merck & Co., Inc. Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Pneumococcal Polysaccharide Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Pneumococcal Polysaccharide Vaccine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Pneumococcal Polysaccharide Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pneumococcal Polysaccharide Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Pneumococcal Polysaccharide Vaccine market is segmented into
    Single Dose Vial
    Pre-Filled Syringe

    Segment by Application, the Pneumococcal Polysaccharide Vaccine market is segmented into
    Children (2-10 Age)
    Adult (10-64 Age)
    Geriatric (More Than 65 Age)

    Regional and Country-level Analysis
    The Pneumococcal Polysaccharide Vaccine market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Pneumococcal Polysaccharide Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Pneumococcal Polysaccharide Vaccine Market Share Analysis
    Pneumococcal Polysaccharide Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pneumococcal Polysaccharide Vaccine business, the date to enter into the Pneumococcal Polysaccharide Vaccine market, Pneumococcal Polysaccharide Vaccine product introduction, recent developments, etc.
    The major vendors covered:
    Merck & Co., Inc.
    Pfizer Inc.
    Glaxosmithkline Plc.
    Sanofi Pasteur
    China National Biotec Group
    Astellas Pharma Inc
    Serum Institute of India Pvt. Ltd
    MSD

    Buy now